Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Trends > Botanicals

Resveratrol player faces bankruptcy if omega-3 funding switch fails: Chairman


By Shane Starling+

Last updated on 03-Oct-2012 at 15:49 GMT2012-10-03T15:49:48Z

Fluxome is hoping fresh investment will avert the road to bankruptcy...

Fluxome is hoping fresh investment will avert the road to bankruptcy...

Global resveratrol player Fluxome has 8-12 weeks to raise millions of euros to fund a research switch to omega-3, or face bankruptcy, its chairman told NutraIngredients this morning.

Jarne Elleholm said, contrary to rumours, the company had not filed for bankruptcy although it faced a serious “funding crisis” that could end that way if one of 3-4 potential investors did not back its planned shift into omega-3s sourced from yeast.

“We are speaking with 3-4 interested parties including industry players and capital funds and expect to have a clear picture on how to move forward in 8-12 weeks,” Elleholm said, noting the figure required was in the seven-figure range.

If the funding failed to eventuate, the company – both its Danish and US operations – faced bankruptcy unless a buy-out partner arose or funding could be found internally.

In the meantime Fluxome filed for “formal reconstruction” in Danish courts last week which again is expected to take 8-12 weeks to resolve. 

Its Danish office is closed while the reconstruction takes place, but Elleholm emphasised that resveratrol supply in the US was "business as usual". 

Elleholm said the resveratrol business was moving steadily ahead in the US, but obviously its performance is not strong enough to have averted the current dilemmas for the company.

“There is an issue and we are managing it in an appropriate way to make ends meet and get the required funding,” Elleholm said.

Fluxome is owned by venture capital firms based in Belgium, France and Denmark.

5 comments (Comments are now closed)

Why is this news?

Another poorly run company is going out of business. Why is this news? When you tie your business model to a single product that has no immediate usefulness to the average consumer you are asking for trouble.

Report abuse

Posted by James
06 October 2012 | 19h052012-10-06T19:05:23Z

Biotivia's dosage conclusion

Biotivia has collaborated with more research organisations on more human clinical trials than all other brands combined. We understand dosage, better I submit, than other manufacturers. Based upon the results of trials done using Bioforte and transmax at Northumbria Univ, Ottawa Hospital (A Health Canada hospital) the National Health Service in the UK, Univ. of Ferrara, Harvard, University of Bologna, the NIH, several health ministries in the EU, The Australian National Health Service (Prince Albert Hosp.) and many others, it is our informed conclusion that the appropriate chemo protective dosage for a 75kg man or woman is between 125mg and 2500mg daily.

The efficacy of RSV is certainly dose dependent and seems to follow a relatively linear progression. To suggest that a dosage of 10mg or anything under a 100mg daily is optimum is simply an uninformed and irresponsible misrepresentation of the evidence.

Report abuse

Posted by James Betz
03 October 2012 | 17h482012-10-03T17:48:31Z

Resveratrol dosage

We have completed a clinical trial on the effects of resveratrol on type 2 diabetes (one might be able to find this study on PubMed). From this and another ongoing study on flow-mediated vasodilation, it seems that the optimal resveratrol dosage is about 2x10 mg daily...

Report abuse

Posted by Laszlo G Meszaros
03 October 2012 | 12h052012-10-03T12:05:52Z

Read all comments (5)

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars